Effect of hemoperfusion on short term outcome of critical ill COVID-19

Phase 3

Recruiting

• Conditions: COVID-19.; COVID-19; U07.1

• Registration Number: IRCT20091012002582N22
• Lead Sponsor: Tabriz University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 7 September 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 160

Inclusion Criteria

Patients 18 to 75 years of age with Covid 19
Absence of active bleeding
Absence of irreversible disease
Existence of pulmonary involvement more than 50%

Exclusion Criteria

Pregnancy
Dissatisfaction of the patient or the patient's companion

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Duration of mechanical ventilation. Timepoint: From the time the patient enters the ICU until discharge from this ward. Method of measurement: Number of days the patient is under mechanical ventilation based on patients recorded information.

Secondary Outcome Measures

Name	Time	Method
Mortality. Timepoint: From the beginning of the interventions to 28 days after the end of the interventions. Method of measurement: Mortality counting based on patients recorded information.;ICU length of stay. Timepoint: From the time of the patient's arrival until the discharge of ICU. Method of measurement: According to the number of days the patient was hospitalized in the ICU.